Cytokeratin 10 Antibody

About the Target

KRT10 is a target of interest in many antibody-based workflows. Keratins, also known as cytokeratins, are intermediate filament proteins predominantly found in epithelial cells. These proteins form heterodimers composed of an acidic keratin (type I keratins, K9-K28) and a basic keratin (type II keratins, K1-K8 and K71-K80), which then assemble into filaments. Keratin isoforms exhibit tissue- and differentiation-specific expression patterns, making them valuable as both research and clinical biomarkers. Depending on the literature source, KRT10 may also be discussed as Cytokeratin 10 and Keratin.

Reported cellular context includes cytoplasm, intermediate filament, and secreted, which can matter when signal is compared across treatments or changing cell states. Following KRT10 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

KRT10 is commonly interpreted in the context of cancer, immunology, and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, intermediate filament, and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, intermediate filament, and secreted across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• context differences tied to immune-cell state, activation, or lineage composition
• cell-cycle linked differences in abundance, timing, or compartmental enrichment

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for KRT10. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in KRT10 reflect biology rather than handling. When interpreting KRT10, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep KRT10 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.